- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01601587
Introduction Seminar About Patient Participation and Treatment Options Decisional Preferences
Introduction Seminar About Patient Participation, Treatment Options and Decisional Preferences for Psychiatric Outpatients on Waiting List
Patient participation (PP) in Hospital is a goal defined by the Norwegian Health Authorities and it is a mandatory activity for District Psychiatric out-patient Centres (DPC) in Norway: patients are entitled to have influence on their treatment and should receive sufficient information directed at empowerment. Nevertheless, studies from Norway have found that patients who seek help are dissatisfied with the information they receive and doubt their possibility for real influence on their treatment. One way to improve individual PP might be to give patients sufficient information and education before they start their treatment in the form of an educational group intervention, an introduction seminar (IS); this group intervention is less time and resource consuming than individual interventions.
Aims: The main purpose of this project is to develop and evaluate an IS for patients on a waiting list of DPC. The seminar will educate patients, so they can actively participate in their own treatment and, thereby, choosing treatment, reducing the risk of dropping out of treatment. Another aim is to enable patients to participate in their own treatment, to cope with their problems while they are waiting for treatment by providing them contact with primary health care and user organizations during their waiting time, and to increase adherence.
Methods: The project involves three components: an exploratory study of educational content of the seminar; RCT of that 4-hours program (to examine its effect on treatment preferences and choices, activation, satisfaction, mental health and cost-benefit) and then a post-seminar qualitative evaluation, which will be used to create a broad yet deep understanding of the practical side of the participants'experience and the seminar's effect.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Part I: An exploratory study of educational content of the seminar: a qualitative study (started october 2011)
Part II (RCT)
The intervention:
The introduction seminar will be held over one half day, 4 hours. Up to 15 patients can participate in each seminar. The content was developed based on study 1. The presentation about available treatment options and patient's rights are made by multi professional health personnel and user representatives. More specifically, this will be done under the following topics:
- What is mental health?
- Treatment options: orientation about individual and group based treatment modalities.
- Former patients experience with their own treatment, self-help and participation.
- How to influence and participate actively in the treatment and patient rights.
- What can I do while I wait for treatment and where can I otherwise do to avoid aggravation?.
At the end of the day, the patients will be divided into small groups mentored by health personnel where they can discuss the presentations and ask questions. In the breaks, literature and other kinds of information for patients will be on display. All participants will get a folder with details of the program and leaflets from patient organisations and governmental agencies.
Sample size Selected Treatment: The number of patients is calculated based on a significance level of 5% and a power of 93%. The numbers needed in each group becomes 25 (calculated using IR), and the aim is to include a total of 52 patients in the RCT. It is controlled that it is feasible to recruit this number of patients.
PAM: Number of patients is calculated based on a significance level of 5% and a power of 87%. The standard deviation is estimated to be 13.8 and 9.7 (Pilot RCT data). The numbers needed in each group becomes 25 (calculated using SamplePower v2.0, SPSS Inc), and the aim is to include a total of 52 patients. It is controlled that it is feasible to recruit this number of patients.
Part III Qualitative and quantitative analysis:
To obtain information about the patients experience after the intervention, a post-seminar qualitative evaluation will be conducted:
15 randomly selected patients will additionally participate in the seminar, and they will be take part in Part III and in the quantitative part of the study.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Trondheim, Norway, 7055
- Tiller DPS
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- older than 18 years
- referred for out-patient treatment
- guarantee of starting treatment between 2 and 4 months
Exclusion Criteria:
- guarantee of starting treatment in less than 2 months
- Patients who do not understand the consequences of taking part of the study
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
No Intervention: Treatment as usual
Patients will receive treatment as usual
|
|
Other: Introduction Seminar
Psychoeducational group
|
The intervention is an introduction seminar. It will be held over FOUR hours. Up to 15 patients can participate in each seminar. The content of the was developed based on study 1. The presentation about available treatment options and patient's rights are made by multi professional health personnel and user representatives. More specifically, this will be done under the following topics:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Selected Treatment
Time Frame: 1 month
|
one single question
|
1 month
|
Health Care utilization
Time Frame: 1 year
|
Health care registration (adherence, attendance, consultations, dropout's rates and cost)
|
1 year
|
Health Care utilization
Time Frame: 2 years
|
Health care registration (adherence, attendance, consultations, dropout's rates and cost)
|
2 years
|
coping
Time Frame: 4 months
|
Patient Activation Measure (PAM-13)
|
4 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Preferences for involvement in treatment decision making
Time Frame: Baseline, 1, 4 and 12 months
|
Control Preferences Scale
|
Baseline, 1, 4 and 12 months
|
Treatment Satisfaction
Time Frame: Baseline, 1, 4, and 12 months
|
Client Satisfaction Questionnaire-8 (CSQ-8)
|
Baseline, 1, 4, and 12 months
|
Quality of Life
Time Frame: Baseline, 1, 4 and 12 months
|
WHO-Five Well-being Index (WHO-5)
|
Baseline, 1, 4 and 12 months
|
Motivation
Time Frame: Baseline, 1, 4 and 12 months
|
One single question about motivation for treatment.
|
Baseline, 1, 4 and 12 months
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: Olav Linaker, md phd, National Taiwan Normal University
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 4.2009.77.2009/1980 ( part 2)
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Mental Health Disorders
-
Virginia Commonwealth UniversityCompletedMental Health DisordersUnited States
-
Johns Hopkins UniversityEunice Kennedy Shriver National Institute of Child Health and Human Development...CompletedMental Health DisordersCongo
-
York UniversityCanadian Institutes of Health Research (CIHR); North York General HospitalCompletedMental Health DisordersCanada
-
VA Boston Healthcare SystemUS Department of Veterans AffairsCompletedMental Health DisordersUnited States
-
University of WarwickKing's College London; KU Leuven; University Hospital, Montpellier; Erasmus Medical... and other collaboratorsUnknownMental Health Disorder | Mental Health ImpairmentIreland, United Kingdom, Netherlands, Germany, Belgium, Croatia, France, Italy
-
University of HaifaCompletedMental Health DisordersIsrael
-
FIDMAG Germanes HospitalàriesUniversity of BarcelonaNot yet recruitingMental Health Disorder | Mental Health Wellness 1 | Nurse's Role | Care Acceptor, Health | Relationship, Nurse Patient
-
Laureate Institute for Brain Research, Inc.Enrolling by invitationMental Health Disorder | Mental Health Issue | Assessment, SelfUnited States
-
University of Colorado, DenverNational Institute of Mental Health (NIMH); University of Pittsburgh; University... and other collaboratorsRecruitingMental Health | Family Health | Mental Disorder, ChildUnited States
-
Boston CollegeUniversity of Georgia; Innovations for Poverty Action; Caritas Freetown; German...CompletedMental Health Disorder | Mental Health Impairment | Psychosocial ProblemSierra Leone
Clinical Trials on A psychoeducational group intervention.
-
Fundacio d'Investigacio en Atencio Primaria Jordi...Hospital Universitari Vall d'Hebron Research Institute; Centre d'Higiene Mental...UnknownDepressive DisordersSpain
-
Clinica Universidad de Navarra, Universidad de...Completed
-
Universidad de MonterreyFEMSA Foundation; Mexican Food BanksCompletedMalnutrition | Malnutrition, Child | Malnutrition in Children | Child Malnutrition | Child Overnutrition | Nutrition Disorders, ChildMexico
-
Emory UniversityNational Institutes of Health (NIH)CompletedHeart Failure | Ventricular ArrhythmiasUnited States
-
University of Texas, El PasoNational Institute on Minority Health and Health Disparities (NIMHD)Not yet recruitingAdherence, Patient | Health Knowledge, Attitudes, Practice | Vaccine-Preventable Diseases | IntentionUnited States
-
Instituto de Investigación Hospital Universitario...Carlos III Health Institute; European Regional Development FundCompletedSchizophrenia and Disorders With Psychotic Features | Psychotic EpisodeSpain
-
Emory UniversityNational Institute on Aging (NIA)Completed
-
University of British ColumbiaCanadian Institutes of Health Research (CIHR)Completed
-
M.D. Anderson Cancer CenterRecruitingFatigue | Metastatic CancersUnited States
-
Copenhagen University Hospital, HvidovreRecruitingCOVID-19 | Anxiety | Mental Health | PsychoeducationDenmark